Introduction
Favism, medically known as glucose-6-phosphate dehydrogenase (G6PD) deficiency, is a genetic enzymatic disorder affecting red blood cells’ ability to withstand oxidative stress. This condition, inherited in an X-linked recessive pattern, primarily impacts males and is especially prevalent in parts of southern China, including Guangdong, Guangxi, Hainan, Yunnan, and Guizhou provinces. The disease manifests clinically when affected individuals are exposed to oxidative agents—most notably, the ingestion of fava beans or contact with certain medications and chemicals—leading to red blood cell destruction, known as hemolysis. Understanding favism is crucial as it can cause sudden, sometimes severe, hemolytic anemia that requires timely diagnosis and appropriate management to prevent complications such as kidney failure and cardiovascular compromise.
Scientific and Clinical Evidence
Genetic and Pathophysiological Background
Favism arises from a deficiency of the G6PD enzyme on red blood cell membranes. G6PD plays a critical role in protecting red blood cells from oxidative damage by maintaining levels of reduced glutathione, an important antioxidant. When G6PD activity is diminished or absent, red blood cells become vulnerable to oxidative injury. After exposure to triggers like fava beans—which contain oxidant vicine and convicine—or certain drugs, such as some antibiotics and anti-malarials, oxidative stress overwhelms the red blood cells, causing premature hemolysis.
The disease’s X-linked inheritance means males, with only one X chromosome, are primarily affected, while females are generally carriers with variable enzyme activity depending on X-chromosome inactivation patterns.
Clinical Manifestations
The latency period following exposure to a trigger can vary widely—from as little as 2 hours to up to 15 days—but usually symptoms emerge within 1-2 days. Clinical presentations correlate with hemolysis severity:
1. Prodromal symptoms: Patients often report non-specific symptoms such as malaise, dizziness, fatigue, weakness, nausea, vomiting, abdominal pain, and fever.
2. Acute hemolytic anemia: Rapid onset of pallor, jaundice (yellowing of the skin and eyes), dark or “soy sauce” colored urine due to hemoglobinuria, and possible enlargement of the liver and spleen.
3. Severe cases: May progress to systemic organ failure presenting with lethargy, shock, seizures, coma, acute kidney injury, and heart failure.
Diagnosis
Diagnosing favism relies on combining clinical history, laboratory testing, and exclusion of other causes:
– Evidence of hemolytic anemia, such as a drop in hemoglobin, elevated reticulocyte count, jaundice, and hemoglobinuria.
– History of recent ingestion of fava beans or exposure to known oxidants.
– Laboratory demonstration of reduced G6PD enzyme activity in red blood cells.
Several biochemical assays are used in clinical practice:
– The methemoglobin reduction test
– Fluorescent spot test
– Nitroblue tetrazolium test
– Quantitative measurement of G6PD activity
However, these tests may yield false negatives during acute hemolysis or after transfusion because young red cells and transfused cells have normal enzyme activity. In such cases, molecular genetic testing using reverse dot blot hybridization can identify specific G6PD gene mutations, providing a definitive diagnosis.
Treatment
The cornerstone of managing favism is prompt removal of precipitating factors and supportive care:
1. Avoidance of triggers: Complete abstinence from fava beans, their products, and oxidative drugs (such as sulfonamides, certain analgesics, and antimalarials) is essential.
2. Blood transfusions: In cases of significant anemia, transfusions restore blood volume and oxygen-carrying capacity. Care must be taken to avoid donor blood from G6PD-deficient individuals or those with recent exposures.
3. Glucocorticoids: While steroids do not directly stop hemolysis, they may be used short-term in severe cases with organ involvement to reduce inflammation and oxidative damage. Studies suggest dexamethasone can inhibit hydrogen peroxide formation and enhance protective enzymes like catalase.
4. Supportive measures: Intravenous fluids correct dehydration and electrolyte imbalances. Urine alkalization helps prevent hemoglobin deposition in kidneys, protecting renal function.
5. Antioxidants: Supplementing with vitamins C and E, coenzyme Q10, and reduced glutathione has shown benefits in reducing oxidative stress. However, high doses of vitamin C can paradoxically exacerbate hemolysis and should be used cautiously.
6. Other supportive care: Oxygen therapy and infection prevention help reduce additional oxidative insults and complications.
Recent adjunctive therapies include intravenous Traditional Chinese Medicine extracts like Danshen and Shengmai injection, which have shown promise in preventing acute renal failure in favism-induced hemolysis, and intravenous immunoglobulin (IVIG), which has helped reduce hemolysis severity.
Practical Guidance and Lifestyle Considerations
Living with G6PD deficiency requires vigilance and lifestyle modifications to prevent hemolytic episodes:
– Strict avoidance of fava beans and products containing them.
– Avoidance of naphthalene-containing mothballs and exposure to certain household chemicals, insecticides, and cleaning agents that may trigger hemolysis.
– Prompt management of infections with medical guidance as illness can precipitate hemolysis.
– Careful immunization under medical supervision.
– Maintaining good personal hygiene and avoiding crowded places during high-infection seasons.
– Regular blood checks every 3 to 6 months to monitor red blood cell and liver-kidney function.
Case Scenario: Jonathan’s Story
Jonathan, a 6-year-old boy of Southern Chinese descent, was brought to the emergency room with sudden fatigue, yellowing of the eyes, and dark urine two days after eating fava beans at a family gathering. His mother reported he felt weak and dizzy, with abdominal discomfort and a mild fever. Laboratory tests confirmed hemolytic anemia, and G6PD enzyme assays showed deficient activity.
Jonathan received supportive care, including blood transfusions and intravenous fluids, and was closely monitored. His family was educated regarding trigger avoidance and the importance of informing healthcare providers about his diagnosis. Over weeks, Jonathan recovered completely and now maintains a trigger-free lifestyle, with regular follow-ups.
Conclusion
Favism or G6PD deficiency is a common enzymatic disorder that can cause serious acute hemolytic anemia upon exposure to oxidative triggers like fava beans and certain drugs. Early diagnosis using clinical history and laboratory tests is essential to prevent morbidity and mortality. Treatment focuses on trigger avoidance, supportive care, and careful monitoring. Patients and families benefit significantly from education about lifestyle adjustments to minimize risk. Advances in genetic testing and adjunct therapies hold promise for improving diagnosis and outcomes.
References
1. Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371(9606):64-74.
2. Luzzatto L, Ally M, Notaro R. Glucose-6-phosphate dehydrogenase deficiency. Hematol Oncol Clin North Am. 2016;30(2):373-393.
3. Beutler E. G6PD deficiency. Blood. 1994;84(11):3613-3636.
4. Ruwende C, Hill A. Glucose-6-phosphate dehydrogenase deficiency and malaria. J Mol Med. 1998;76(8):581-588.
5. Vives-Corrons JL, et al. Molecular characterization of glucose-6-phosphate dehydrogenase gene in Chinese patients. Br J Haematol. 2008;140(6):805-810.
6. Xiao W, et al. Clinical effects of intravenous Danshen and Shengmai injection in treating acute renal failure in favism. J Tradit Chin Med. 2020;40(5):627-632.
7. Beutler E. Glucose-6-phosphate dehydrogenase deficiency: a historical perspective. Blood Cells Mol Dis. 2008;41(3):247-258.